Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-23

Clinical Trial Update: Study of the Macular Pigment by the Consumption of Corn With Strong Content in Zeaxanthine [NA]

View source ↗

Summary

Completed trial evaluating whether consuming corn with high zeaxanthin content affects macular pigment in age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Age Macular Degeneration | NA | Status: COMPLETED